LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 61.56 | 27.76 | 3340 | 6217 | 0.5372 | 0.8470 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 63.26 | 27.76 | 2451 | 6465 | 0.3791 | 0.7679 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 63.26 | 27.76 | 2484 | 6465 | 0.3842 | 0.7709 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 63.26 | 27.76 | 2977 | 6465 | 0.4604 | 0.8122 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 63.26 | 27.76 | 3040 | 6465 | 0.4702 | 0.8170 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 63.26 | 27.76 | 3275 | 6465 | 0.5065 | 0.8343 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 63.26 | 27.76 | 3484 | 6465 | 0.5389 | 0.8488 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 64.97 | 27.76 | 2536 | 6656 | 0.3810 | 0.7702 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 64.97 | 27.76 | 2571 | 6656 | 0.3862 | 0.7733 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 64.97 | 27.76 | 3090 | 6656 | 0.4642 | 0.8150 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 64.97 | 27.76 | 3158 | 6656 | 0.4744 | 0.8200 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 64.97 | 27.76 | 3407 | 6656 | 0.5118 | 0.8375 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 64.97 | 27.76 | 3611 | 6656 | 0.5425 | 0.8511 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 66.67 | 27.76 | 2657 | 6695 | 0.3968 | 0.7796 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 66.67 | 27.76 | 2694 | 6695 | 0.4024 | 0.7827 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 66.67 | 27.76 | 3115 | 6695 | 0.4652 | 0.8157 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 66.67 | 27.76 | 3266 | 6695 | 0.4878 | 0.8266 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 66.67 | 27.76 | 3254 | 6695 | 0.4860 | 0.8257 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 66.67 | 27.76 | 3737 | 6695 | 0.5581 | 0.8579 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 68.37 | 27.76 | 2732 | 6879 | 0.3971 | 0.7808 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 68.37 | 27.76 | 2775 | 6879 | 0.4034 | 0.7843 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 68.37 | 27.76 | 3284 | 6879 | 0.4774 | 0.8224 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 68.37 | 27.76 | 3412 | 6879 | 0.4960 | 0.8312 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 68.37 | 27.76 | 2316 | 6879 | 0.3367 | 0.7441 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 68.37 | 27.76 | 3863 | 6879 | 0.5616 | 0.8600 | MN20160318_Q01 | L08 |